Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C
NCT00309517Phase 3Terminated
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Jul 1997
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of edrecolomab in rectal cancer, sponsored by Austrian Breast and Colorectal Cancer Study Group. Started Jul 1997; status: terminated.
02
Drugs
edrecolomab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00309517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309517.